Skip to main content
. 2021 Jul 21;374:n1647. doi: 10.1136/bmj.n1647

Table 3.

Mixed model, repeated measures analysis of change from baseline using γ model

Variable Adjusted* least squares mean (95% CI) Adjusted* mean difference (95% CI)
Intervention Standard care Intervention v standard care P value
Total MSAS 0.36 (0.34 to 0.39) 0.52 (0.49 to 0.54) −0.15 (−0.19 to −0.12) <0.001
MSAS global distress index 0.46 (0.42 to 0.50) 0.67 (0.63 to 0.71) −0.21 (−0.27 to −0.16) <0.001
MSAS psychological 0.51 (0.46 to 0.55) 0.67 (0.63 to 0.72) −0.16 (−0.23 to −0.10) <0.001
MSAS physical 0.33 (0.30 to 0.36) 0.54 (0.51 to 0.58) −0.21 (−0.26 to −0.17) <0.001
FACT-G total 86.3 (85.3 to 87.3) 82.3 (81.3 to 83.3) 4.06 (2.65 to 5.46) <0.001
FACT-G physical 23.4 (21.3 to 23.7) 21.6 (21.3 to 22.0) 1.75 (1.25 to 2.25) <0.001
FACT-G emotional 20.4 (20.2 to 20.7) 19.9 (19.6 to 20.1) −0.54 (−1.23 to 0.16) 0.13
FACT-G social 23.6 (23.2 to 23.9) 23.2 (22.8 to 23.5) 0.44 (−0.06 to 0.93) 0.08
FACT-G functional 19.1 (18.7 to 19.5) 17.5 (17.1 to 17.9) 1.61 (1.00 to 2.22) <0.001
STAI-R trait 32.7 (32.2 to 33.3) 33.9 (33.4 to 34.4) −1.15 (−1.90 to −0.41) 0.003
STAI-R state 31.9 (31.2 to 32.6) 33.0 (32.4 to 33.7) −1.13 (−2.06 to −0.20) 0.02
CASE-Cancer 43.7 (43.3 to 44.2) 42.9 (42.3 to 43.4) 0.81 (0.19 to 1.43) 0.01
SCNS-SF34 psychological 23.2 (21.9 to 24.6) 24.4 (23.0 to 25.8) −1.14 (−3.04 to 0.75) 0.24
SCNS-SF34 health system and information 22.3 (21.1 to 23.4) 23.7 (22.5 to 24.9) −1.46 (−3.13 to 0.21) 0.09
SCNS-SF34 sexuality needs 12.0 (10.9 to13.1) 13.5 (12.4 to 14.7) −1.56 (−3.11 to −0.01) <0.05
SCNS-SF34 patient care and support 17.5 (16.5 to 18.6) 19.3 (18.1 to 20.4) −1.74 (−3.31 to −0.16) 0.03
SCNS-SF34 physical and daily living 27.3 (25.7 to 28.8) 30.0 (28.5 to 31.6) −2.8 (−5.0 to −0.6) 0.01

CASE-Cancer=Communication and Attitudinal Self-Efficacy scale for cancer; FACT-G=Functional Assessment of Cancer Therapy—General; MSAS=Memorial Symptom Assessment Scale; SCNS-SF34=Supportive Care Needs Survey Short-Form; STAI=State-Trait Anxiety Inventory.

*

Adjusted for baseline patient reported outcome measure, cycle, age, sex, cancer type, comorbidity, and country.

Primary outcome.